share_log

Maxim Group Initiates Coverage On Heart Test Laboratories With Buy Rating, Announces Price Target of $8

Benzinga Real-time News ·  Nov 9, 2022 22:06

Maxim Group analyst Allen Klee initiates coverage on Heart Test Laboratories (NASDAQ:HSCS) with a Buy rating and announces Price Target of $8.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment